Cite
HARVARD Citation
Ferrandina, G. et al. (2017). Real-World Management of Trabectedin/Pegylated Liposomal Doxorubicin in Platinum-Sensitive Recurrent Ovarian Cancer Patients: A National Survey. International journal of gynecological cancer. 27 (6), pp. 1141-1148. [Online].